The store will not work correctly when cookies are disabled.
2-Benzyl-2,3-dihydro-9-phenyl-1H-indeno[2,1-c]pyridire Hydrobromide
ID: ALA3249178
PubChem CID: 21511016
Max Phase: Preclinical
Molecular Formula: C25H22BrN
Molecular Weight: 335.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Br.C1=C2C(=C(c3ccccc3)c3ccccc32)CN(Cc2ccccc2)C1
Standard InChI: InChI=1S/C25H21N.BrH/c1-3-9-19(10-4-1)17-26-16-15-22-21-13-7-8-14-23(21)25(24(22)18-26)20-11-5-2-6-12-20;/h1-15H,16-18H2;1H
Standard InChI Key: VQILBAOKFWGFNU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
13.4283 -19.6194 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
11.0934 -18.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3941 -17.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4106 -17.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1265 -16.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8258 -17.1341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8092 -17.9511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6119 -18.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1451 -17.4884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3343 -17.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0171 -16.6334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5107 -15.9821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3216 -16.0840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6387 -16.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3437 -18.9310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5411 -19.0847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2728 -19.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8072 -20.4748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6098 -20.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8781 -19.5493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5085 -18.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2440 -18.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9202 -18.4767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6557 -18.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7150 -17.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0388 -16.8466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3033 -17.2028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
2 7 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
3 8 2 0
4 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
8 15 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
22 27 2 0
7 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.45 | Molecular Weight (Monoisotopic): 335.1674 | AlogP: 5.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 3.24 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.20 | CX LogP: 5.23 | CX LogD: 4.37 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.62 | Np Likeness Score: -0.01 |
References
1. Ellefson CR, Woo CM, Cusic JW.. (1978) Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives., 21 (4): [PMID:650662] [10.1021/jm00202a005] |